FDA 483 OBSERVATION · #791 OF 1,000 MOST-CITED
Lack of records
FDA cited this observation 19 times across 17 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.
How FDA worded it — real examples
You do not have records to document the performance and results of the affirmative steps taken to demonstrate that fish and fishery products imported into the United States were processed in accordance with the seafood HACCP regulation.
You do not have records to document the performance and results of the affirmative steps taken to demonstrate that fishery products imported into the United States were processed in accordance with the seafood HACCP regulation.
You do not have records to document the performance and results of the affirmative steps taken to demonstrate that fish and fishery products imported into the United States were processed in accordance with the seafood HACCP regulation.
You do not have records to document the performance and results of the affirmative steps taken to demonstrate that fish and fishery products imported into the United States were processed in accordance with the seafood HACCP regulation.
You do not have records to document the performance and results of the affirmative steps taken to demonstrate that fish and fishery products imported into the United States were processed in accordance with the seafood HACCP regulation.
You do not have records to document the performance and results of the affirmative steps taken to demonstrate that fishery products imported into the United States were processed in accordance with the seafood HACCP regulation.
Related SPEQ references
Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.
Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.
Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.